Tag: Pfizer

US Regulators Authorize Pfizer COVID-19 Booster for Children as Young as 5

Americans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded emergency authorization for Pfizer’s shot. The regulatory agency expanded clearance of a third Pfizer shot to children aged 5 to 11 at least five months after their second dose. The extra shot…


Pfizer’s COVID Vaccine Protection Against Omicron Fades After a Few Weeks: Study

The protection afforded against the Omicron COVID-19 variant fades quickly after a second and third dose of Pfizer-BioNtech’s vaccine, according to a peer-reviewed study published in the JAMA Network. A Danish study published in JAMA Network on May 13 found there was a rapid decline in Omicron-specific serum neutralizing antibodies only a few weeks after the…


Young Pfizer COVID-19 Vaccine Recipients More Likely to Get Infected After 5 Months

The Pfizer COVID-19 vaccine turned negatively effective after five months, according to a new study. Researchers with the U.S. Centers for Disease Control and Prevention (CDC) analyzed test results from sites across the United States and determined that the vaccine was 60 percent effective two to four weeks after 12- to 15-year-olds got the second…


Pfizer to Pay $11.6 Billion for Biohaven to Tap Migraine Market

Pfizer Inc said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co, making a big bet on its ability to boost sales of the top-selling pill in a new class of migraine drugs. The boards of both companies have approved the deal, they said. Biohaven shares jumped 70 percent to $141.31,…


Fed Hikes Rates Half a Point, Most Since 2000; EU Proposes Total Ban on Russian Oil | NTD Business

The Federal Reserve is raising interest rates by half a percentage point to fight inflation, but will it slow the economy to a recession? The European Union is proposing a sixth round of sanctions. This time it includes all Russian oil, and even Germany is in. Pharmaceutical companies Pfizer and Moderna rake in high profits from selling their…


FDA Investigating Reports of COVID Relapses Following Use of Pfizer’s Pill

The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report,…


Pfizer Stock Flies Higher Following Q1 Earnings Print: Here’s What to Watch for Next

Pfizer, Inc shot up over 3 percent on Tuesday after printing its first-quarter earnings before the market open. The pharmaceutical giant reported adjusted earnings per share of $1.62, which beat the consensus estimate of $1.50. Pfizer reported sales of $25.70 billion, beating the $23.95 billion estimate. $13.2 billion of Pfizer’s sales came from its COVID-19 vaccine….


Pfizer Surpasses Q1 Earnings Predictions

Pharmaceutical company Pfizer released its quarterly earnings report on Tuesday, delivering better-than-expected results with strong sales of its antiviral drug Paxlovid and the company’s vaccine for the CCP (Chinese Communist Party) virus. In the recent financial quarter, Pfizer reported net income of $7.864 billion, almost $3 billion higher than net income for the previous quarter ($4.877…


Pfizer Says Its COVID-19 Pill Paxlovid Fails to Prevent Symptomatic Infection of Household Members

Pfizer announced Friday that a recent large, late-stage trial found that its COVID-19 antiviral pill, Paxlovid, failed at preventing symptomatic infection of people living with a person who has the disease. The trial enrolled 2,957 participants aged 18 and older who live in the same household as another person who has COVID-19 with symptoms. They were given either…


Capitol Report (April 29): Trump Returns to Social Media

With illegal immigration surging at the southern border, President Joe Biden and Mexico’s president spoke on Friday. What’s their plan? For decades at the southern border, illegal immigrants have mostly originated from Mexico and other Central and South American countries, but now Border Patrol is catching people from countries all over the world—even from countries that…